NEOGENOMICS, INC. Form 8-K Filing Summary

NeoGenomics, Inc. held its annual stockholder meeting on May 21, 2026. Key outcomes include the approval of an amendment to the 2023 Equity Incentive Plan to increase the number of authorized shares by 5,000,000. Stockholders also elected nine directors to the Board, approved an advisory vote on executive compensation, and ratified the appointment of Deloitte & Touche LLP as the independent registered public accountant. The meeting saw a high turnout, with approximately 89.61% of outstanding voting stock represented. The election of directors and the amendment to the Equity Incentive Plan received significant support, as did the ratification of the auditor appointment.